Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Oncolytic Virus Immunotherapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oncolytic Virus Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Oncolytic Virus Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Amgen
Sorrento Therapeutics
Oncorus
Merck
TILT Biotherapeutics
Shanghai Sunway Biotech
By Type:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncolytic Virus Immunotherapy Market
-
1.3 Market Segment by Type
-
1.3.1 China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Engineering Oncolytic Viruses from 2016 to 2027
-
1.3.2 China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Wild-Type Oncolytic Viruses from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Oncolytic Virus Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncolytic Virus Immunotherapy by Major Types
-
3.4.1 Market Size and Growth Rate of Engineering Oncolytic Viruses
-
3.4.2 Market Size and Growth Rate of Wild-Type Oncolytic Viruses
4 Segmentation of Oncolytic Virus Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncolytic Virus Immunotherapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Oncolytic Virus Immunotherapy in Hospitals
-
4.4.2 Market Size and Growth Rate of Oncolytic Virus Immunotherapy in Clinics
-
4.4.3 Market Size and Growth Rate of Oncolytic Virus Immunotherapy in Ambulatory Surgical Centers
5 Market Analysis by Regions
-
5.1 China Oncolytic Virus Immunotherapy Production Analysis by Regions
-
5.2 China Oncolytic Virus Immunotherapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Oncolytic Virus Immunotherapy Landscape Analysis
-
6.1 North China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
6.2 North China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
7 Central China Oncolytic Virus Immunotherapy Landscape Analysis
-
7.1 Central China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
7.2 Central China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
8 South China Oncolytic Virus Immunotherapy Landscape Analysis
-
8.1 South China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
8.2 South China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
9 East China Oncolytic Virus Immunotherapy Landscape Analysis
-
9.1 East China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
9.2 East China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
10 Northeast China Oncolytic Virus Immunotherapy Landscape Analysis
-
10.1 Northeast China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
10.2 Northeast China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
11 Southwest China Oncolytic Virus Immunotherapy Landscape Analysis
-
11.1 Southwest China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
11.2 Southwest China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
12 Northwest China Oncolytic Virus Immunotherapy Landscape Analysis
-
12.1 Northwest China Oncolytic Virus Immunotherapy Landscape Analysis by Major Types
-
12.2 Northwest China Oncolytic Virus Immunotherapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Amgen
-
13.1.1 Amgen Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Sorrento Therapeutics
-
13.2.1 Sorrento Therapeutics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Oncorus
-
13.3.1 Oncorus Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Merck
-
13.4.1 Merck Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 TILT Biotherapeutics
-
13.5.1 TILT Biotherapeutics Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Shanghai Sunway Biotech
-
13.6.1 Shanghai Sunway Biotech Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Engineering Oncolytic Viruses from 2016 to 2027
-
Figure China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Wild-Type Oncolytic Viruses from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Oncolytic Virus Immunotherapy Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Oncolytic Virus Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Oncolytic Virus Immunotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncolytic Virus Immunotherapy by Different Types from 2016 to 2027
-
Table Consumption Share of Oncolytic Virus Immunotherapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Engineering Oncolytic Viruses
-
Figure Market Size and Growth Rate of Wild-Type Oncolytic Viruses
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Oncolytic Virus Immunotherapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Oncolytic Virus Immunotherapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Table China Oncolytic Virus Immunotherapy Production by Regions
-
Table China Oncolytic Virus Immunotherapy Production Share by Regions
-
Figure China Oncolytic Virus Immunotherapy Production Share by Regions in 2016
-
Figure China Oncolytic Virus Immunotherapy Production Share by Regions in 2021
-
Figure China Oncolytic Virus Immunotherapy Production Share by Regions in 2027
-
Table China Oncolytic Virus Immunotherapy Consumption by Regions
-
Table China Oncolytic Virus Immunotherapy Consumption Share by Regions
-
Figure China Oncolytic Virus Immunotherapy Consumption Share by Regions in 2016
-
Figure China Oncolytic Virus Immunotherapy Consumption Share by Regions in 2021
-
Figure China Oncolytic Virus Immunotherapy Consumption Share by Regions in 2027
-
Table North China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table North China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table North China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table North China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure North China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table Central China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table Central China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table Central China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Central China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure Central China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table South China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table South China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table South China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table South China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure South China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table East China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table East China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table East China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table East China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure East China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table Northeast China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northeast China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table Northeast China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northeast China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table Southwest China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table Southwest China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table Southwest China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure Southwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table Northwest China Oncolytic Virus Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northwest China Oncolytic Virus Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2016
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2021
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by Types in 2027
-
Table Northwest China Oncolytic Virus Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northwest China Oncolytic Virus Immunotherapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Sorrento Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics
-
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics
-
Figure Revenue and Market Share Analysis of Sorrento Therapeutics
-
Table Product and Service Introduction of Sorrento Therapeutics
-
Table Company Profile and Development Status of Oncorus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncorus
-
Figure Sales and Growth Rate Analysis of Oncorus
-
Figure Revenue and Market Share Analysis of Oncorus
-
Table Product and Service Introduction of Oncorus
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of TILT Biotherapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TILT Biotherapeutics
-
Figure Sales and Growth Rate Analysis of TILT Biotherapeutics
-
Figure Revenue and Market Share Analysis of TILT Biotherapeutics
-
Table Product and Service Introduction of TILT Biotherapeutics
-
Table Company Profile and Development Status of Shanghai Sunway Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Sunway Biotech
-
Figure Sales and Growth Rate Analysis of Shanghai Sunway Biotech
-
Figure Revenue and Market Share Analysis of Shanghai Sunway Biotech
-
Table Product and Service Introduction of Shanghai Sunway Biotech
-
